Probate
Brand names,
Probate
Analogs
Probate
Brand Names Mixture
Probate
Chemical_Formula
C20H23NS
Probate
RX_link
No information avaliable
Probate
fda sheet
Probate
msds (material safety sheet)
Probate
Synthesis Reference
No information avaliable
Probate
Molecular Weight
309.469 g/mol
Probate
Melting Point
< 25 oC
Probate
H2O Solubility
Soluble as HCl salt
Probate
State
Liquid
Probate
LogP
5.7
Probate
Dosage Forms
Tablets (oral, 1 mg)
Probate
Indication
Used for the symptomatic treatment of parkinsonism.
Probate
Pharmacology
Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.
Probate
Absorption
Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.
Probate
side effects and Toxicity
Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
Probate
Patient Information
Probate
Organisms Affected
Humans and other mammals